iOnctura to present late-breaking data on roginolisib in immunotherapy resistant NSCLC at SITC

Summary

Data from the ongoing PULMO-01 clinical study to be presented on November 6, 2026, at SITC 2026 Roginolisib is the first conformation-selective PI3Kδ inhibitor that locks the enzyme in its inactive state CAMBRIDGE,...